Pediatrix Medical Group, Inc. (MD)
(Delayed Data from NYSE)
$12.11 USD
+0.11 (0.92%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $12.12 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Price, Consensus and EPS Surprise
MD 12.11 +0.11(0.92%)
Will MD be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for MD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MD
MD vs. AVTR: Which Stock Should Value Investors Buy Now?
Pediatrix Medical Up 45.8% in 3 Months: Is it Too Late to Jump In?
MD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Pediatrix Medical Group (MD)'s Technical Outlook is Bright After Key Golden Cross
Why Is Pediatrix Medical Group (MD) Up 9.5% Since Last Earnings Report?
Pediatrix Medical Group (MD) Shows Fast-paced Momentum But Is Still a Bargain Stock
Other News for MD
Pediatrix Medical price target raised by $3 at Truist, here's why
Pediatrix upped to buy by Jefferies, free cash flow cited
Pediatrix Medical Group Inc (MD) Shares Up 5.85% on Sep 26
Starbucks upgraded, Hershey downgraded: Wall Street's top analyst calls
Pediatrix Medical just upgraded at Jefferies, here's why